Comment from Ginkgo Bioworks

Summary: Ginkgo Bioworks, a cell and protein engineering company, supports a shift toward a science-based, product-focused regulatory framework for modified organisms. They argue that the current process-based system under 7 CFR Part 340 creates excessive costs and delays, and they recommend deregulating non-food GM crops and aligning the regulation of GE organisms with those of conventionally bred organisms.